Dietl Charles A, Wernly Jorge A, Pett Stuart B, Yassin Said F, Sterling José P, Dragan Robert, Milligan Karen, Crowley Mark R
Division of Thoracic and Cardiovascular Surgery, Department of Surgery, University of New Mexico Health Sciences Center, Albuquerque, NM 87131-0001, USA.
J Thorac Cardiovasc Surg. 2008 Mar;135(3):579-84. doi: 10.1016/j.jtcvs.2007.11.020. Epub 2008 Jan 18.
The purposes of this study are to evaluate the outcome of extracorporeal membrane oxygenation support in a subgroup of patients with Hantavirus cardiopulmonary syndrome who had a predicted mortality of 100% and to assess the complications associated with this treatment modality and with different cannulation techniques.
Thirty-eight patients with severe Hantavirus cardiopulmonary syndrome were supported with extracorporeal membrane oxygenation between April 1994 and June 2006. Cannulation of the femoral vessels was performed on an emergency basis by a percutaneous approach in 15 (39.5%) and by an open technique in 23 (60.5%) patients. Duration of extracorporeal membrane oxygenation averaged 132 hours (range: 5-276 hours).
Complications from percutaneous cannulation occurred in 4 (26.6%) of 15 patients: retroperitoneal hematoma in 2 (13.3%) and lower extremity ischemia in 2 (13.3%) patients, which resolved after insertion of a distal perfusion cannula. Complications from open femoral cannulation occurred in 8 (34.8%) of 23 patients: severe bleeding in 7 (30.4%) patients and lower extremity ischemia in 1 (4.3%) patient who required a leg amputation. The overall survival was 60.5% (23/38 patients). Six (40%) of the 15 patients cannulated percutaneously and 9 (39.1%) of 23 patients who had open cannulation died. All survivors recovered completely and were discharged from the hospital after a mean hospital stay of 20.8 days (range: 10-39 days).
Almost two thirds of the patients with severe Hantavirus cardiopulmonary syndrome who were supported with extracorporeal circulation survived and recovered completely. The complications associated with both types of femoral cannulation may be attributed to the fact that all patients were in shock or in full cardiac arrest, and the procedure had to be done expeditiously. Earlier institution of extracorporeal membrane oxygenation may decrease the complication rates and improve the overall survival.
本研究旨在评估体外膜肺氧合支持对一组预测死亡率为100%的汉坦病毒心肺综合征患者的治疗效果,并评估与这种治疗方式及不同插管技术相关的并发症。
1994年4月至2006年6月期间,38例重症汉坦病毒心肺综合征患者接受了体外膜肺氧合支持治疗。15例(39.5%)患者采用经皮穿刺法紧急进行股血管插管,23例(60.5%)患者采用开放技术插管。体外膜肺氧合的持续时间平均为132小时(范围:5 - 276小时)。
15例经皮穿刺插管患者中有4例(26.6%)出现并发症:2例(13.3%)发生腹膜后血肿,2例(13.3%)出现下肢缺血,在插入远端灌注插管后症状缓解。23例开放股动脉插管患者中有8例(34.8%)出现并发症:7例(30.4%)严重出血,1例(4.3%)出现下肢缺血并需要截肢。总体生存率为60.5%(23/38例患者)。15例经皮穿刺插管患者中有6例(40%)死亡,23例开放插管患者中有9例(39.1%)死亡。所有幸存者均完全康复,平均住院20.8天(范围:10 - 39天)后出院。
接受体外循环支持的重症汉坦病毒心肺综合征患者中,近三分之二存活并完全康复。两种股动脉插管相关的并发症可能归因于所有患者均处于休克或完全心脏骤停状态,且手术必须迅速进行。更早开始体外膜肺氧合可能降低并发症发生率并提高总体生存率。